Trademarkia Logo

Canada

C$
APVARDI
REGISTERED

on 10 Feb 2025

Last Applicant/ Owned by

Alexion Pharmaceuticals, Inc.

121 Seaport BoulevardBoston MA 02210

US

Serial Number

2235723 filed on 21st Dec 2022

Registration Number

TMA1289770 registered on 10th Feb 2025

Registration expiry Date

21st Dec 2032

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

CA

K1P5Y6

APVARDI

Trademark usage description

pharmaceutical preparations for the treatment of complement-mediated hematological, nephrological, autoimmune, immunological, ocular, neurological, an Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of complement-mediated hematological, nephrological, autoimmune, immunological, ocular, neurological, and inflammatory-related diseases and disorders.


Classification kind code

11

Mark Details


Serial Number

2235723

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 17th Jan 2024
Agent Changed
Submitted for opposition 256
on 27th Nov 2023
Notification of Possible Opposition Sent
Submitted for opposition 22
on 21st Aug 2023
Search Recorded
Submitted for opposition 20
on 21st Aug 2023
Examiner's First Report
Submitted for opposition 223
on 21st Aug 2023
Total Provisional Refusal
Submitted for opposition 257
on 26th Jan 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 25th Jan 2023
Formalized
Submitted for opposition 1
on 25th Jan 2023
Created
Submitted for opposition 228
on 21st Dec 2022
International Registration
Submitted for opposition 30
on 21st Dec 2022
Filed